Photo from wikipedia
Patients with diabetes are more likely to suffer COVID‐19 complications. Using noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved challenging. In this study, we evaluate different noninsulin AGMs in… Click to show full abstract
Patients with diabetes are more likely to suffer COVID‐19 complications. Using noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved challenging. In this study, we evaluate different noninsulin AGMs in patients with COVID‐19.
Keywords:
medications patients;
antihyperglycemic medications;
noninsulin based;
diabetes covid;
based antihyperglycemic;
patients diabetes
Journal Title: Journal of Diabetes
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Diabetes
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!